Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
03/2008
03/26/2008EP1660460B1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
03/26/2008EP1509218A4 Peptide deformylase inhibitors
03/26/2008EP1196396B1 Pharmacologically active compounds with two covalently linked active principles (sodium channnel blocker/p2y2 receptor agonist) for the treatment of mucosal surfaces
03/26/2008CN101151270A Organometallic complex and light emitting element using the same, and electronic device
03/25/2008US7348328 MCH antagonists for the treatment of obesity
03/25/2008US7348324 Cyclic amine compounds as CCR5 antagonists
03/20/2008WO2008031743A1 Heterocyclic bridged biphenyls and their use in oleds
03/20/2008WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
03/20/2008WO2008019090A3 Agonists of the sphingosine-1-phosphate receptor
03/20/2008WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/20/2008US20080071084 Method for preparing alkyl ethers and aryl ethers
03/20/2008US20080070921 Melanocortin receptor modulators; sexual disorders, obesity, cachexia, eating disorders; for example 1,4-bis(2-amino-3-p-tolyl-propionyl)-2-isobutyl-5-(4-(2-aminoethylamino)butyl)piperazine
03/20/2008US20080070919 Serotonin reuptake inhibitors and antagonists of the serotonin 1A receptor; compounds are based on 7,9-diazabicyclo(4.2.2)dec-3-ene ring
03/20/2008US20080069851 Substituted n-aminomethylene sulfonamides, production and use thereof as medicaments
03/20/2008CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors
03/19/2008CN101146786A Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
03/19/2008CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics
03/19/2008CN101143852A Method for preparing cyclodipeptide cyclo(L-Asp-L-Pro)
03/19/2008CN101143851A Ligustrazine aromatic acid ether derivatives, preparation method thereof, medicament composition and use
03/18/2008US7345172 Intercalation compound for use in the diagnosis and detection of genetic disorders; sterically demanding nucleotide intercalating compounds and methods for detecting base pair mismatches in nucleic acid sequences
03/18/2008US7345044 Sodium channel blockers
03/18/2008US7345041 Chemical compounds
03/13/2008WO2008030843A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
03/13/2008WO2008029282A2 Aqueous formulation comprising an antitumor agent
03/13/2008WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
03/13/2008US20080064872 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity
03/13/2008US20080064871 Production Method of Nitrogen-Containing Fused Ring Compounds
03/13/2008US20080064748 Substituted enaminones, their derivatives and uses thereof
03/13/2008US20080064708 Substituted Pyrazinecarboxylic Acid Anilde Dervatives Or Salts Thereof, Intermediates Of The Same, Pesticides for Agricultural And Horticultural Use, and Usage Thereof
03/13/2008US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency
03/13/2008US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
03/13/2008CA2662852A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
03/13/2008CA2662850A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity
03/13/2008CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
03/13/2008CA2660685A1 Aqueous formulation comprising an antitumor agent
03/12/2008EP1897542A1 Aqueous formulation comprising an antitumor agent
03/12/2008EP1656355B1 Piperazine derivatives and methods of use
03/12/2008CN101139323A Method for refining dexrazoxane
03/12/2008CN101139267A White black falsehellebore alcohol derivative, analogue and preparation method and use thereof
03/12/2008CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers
03/12/2008CN100374416C P-(sulfonyl)-aryl and heteroaryls amines
03/12/2008CN100374115C Substituted diketopiperazines as oxytocin antagonists
03/11/2008US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis
03/11/2008US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists
03/11/2008CA2293382C Piperazine derivatives and their use as anti-inflammatory agents
03/06/2008WO2008025867A1 Compounds that act as a vehicle for delivery through the blood-brain barrier and charge delivery vehicle constructions
03/06/2008WO2007096193A3 Radiolabelled carbamates
03/06/2008US20080058521 Processes for the preparation of compounds
03/06/2008CA2661842A1 Serine-threonine protein kinase and parp modulators
03/05/2008EP1893207A1 Use of substituted piperazine derivatives and morpholine derivatives
03/04/2008US7338553 6,13-Dihydropyrazino[2,3-b:5,6-b]diquinoxaline derivatives for use in ink jet printers; particularly good ozone fastness
02/2008
02/28/2008WO2008023357A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr)
02/28/2008WO2008022396A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors
02/28/2008US20080051415 Novel piperazines, pharmaceutical compositions and methods of use thereof
02/28/2008US20080051414 Protein Kinase Inhibitors
02/28/2008US20080051411 choline fenofibrate, or fenofibric acid salts of ethanolamine, diethanolamine, piperazine, calcium or tromethamine; salts have improved photostability; hyperlipidemia or coronary heart diseases
02/28/2008US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents
02/28/2008CA2661307A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr)
02/28/2008CA2660169A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors
02/27/2008EP1749032B1 Alkoxyamines containing a radically polymerizable group
02/27/2008EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors
02/27/2008CN100371330C Method for purifying polyhydroxy alkyl pyrazine compound from browning reaction liquor
02/27/2008CN100370975C Inhibitors against the production and releaseof inflammator cytokines
02/26/2008US7335788 S-(α, α′-disubstituted-α″-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom
02/26/2008US7335653 Bis-aryl sulfonamides
02/21/2008WO2008021956A2 Acylaminoheteroaryl hepatitis c virus protease inhibitors
02/21/2008WO2008020124A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
02/21/2008WO2007149448A3 Pyrazinones as cellular proliferation inhibitors
02/21/2008US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds
02/21/2008US20080045620 Piperazino Based Photoinitiators
02/21/2008US20080045537 Chemical Compounds
02/21/2008US20080045530 Organic Compounds and Their Uses
02/21/2008US20080045516 Viral Polymerase Inhibitors
02/21/2008US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents
02/21/2008US20080045470 Ceramides and Apoptosis-Signaling Ligand
02/21/2008US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A)
02/21/2008CA2661093A1 Dicer substrate rna peptide conjugates and methods for rna therapeutics
02/21/2008CA2660911A1 Thiourea compounds
02/21/2008CA2660560A1 Pyrazine compounds, their use and methods of preparation
02/21/2008CA2660474A1 Arylpiperazine derivatives and uses thereof
02/21/2008CA2659928A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
02/20/2008EP1889845A1 Novel pleuromutilin derivatives
02/20/2008EP1888707A1 New materials for organic electroluminescence devices
02/20/2008EP1888570A2 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
02/20/2008EP1436271B1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
02/20/2008CN101128439A 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis
02/20/2008CN101125138A Inhibitors against the production and release of inflammatory cytokines
02/19/2008US7332623 Aryl-substituted acyclic enediyne compounds
02/19/2008US7332511 Vanilloid receptor ligands and their use in treatments
02/19/2008US7332496 Methods of using sodium channel blockers
02/19/2008US7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent
02/19/2008US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease
02/19/2008US7332153 Cosmetic compositions
02/19/2008CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
02/14/2008WO2008019292A2 Compositions and methods for potentiating antibiotic activity
02/14/2008WO2008019090A2 Agonists of the sphingosine-1-phosphate receptor
02/14/2008WO2008018778A1 New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer
02/14/2008WO2008018544A1 Sulfonamide compound or salt thereof
02/14/2008WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
02/14/2008WO2008017852A1 Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 187